Page last updated: 2024-11-05

vesnarinone and Coronary Heart Disease

vesnarinone has been researched along with Coronary Heart Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feldman, AM1
Baughman, KL1
Lee, WK1
Gottlieb, SH1
Weiss, JL1
Becker, LC1
Strobeck, JE1
Nanto, S1
Kodama, K2
Kimura, Y1
Masuyama, T1
Mishima, M1
Hamanaka, Y1
Hori, M3
Inoue, M3
Sasayama, S1
Asanoi, H1
Sakurai, T1
Kawai, C1
Tamai, J1
Koretsune, Y1
Kitakaze, M1
Iwai, K1
Iwakura, K1
Kamada, T1

Trials

1 trial available for vesnarinone and Coronary Heart Disease

ArticleYear
Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
    The American journal of cardiology, 1991, Nov-01, Volume: 68, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardioton

1991

Other Studies

3 other studies available for vesnarinone and Coronary Heart Disease

ArticleYear
Effect of OPC-8212 (2(1H)-quinolinone), a new inotropic agent, on myocardial energy metabolism in patients with coronary heart disease.
    Japanese circulation journal, 1988, Volume: 52, Issue:2

    Topics: Adult; Aged; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Energy Metabolism; Heart; H

1988
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
    Heart and vessels, 1986, Volume: 2, Issue:1

    Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coro

1986
Beneficial effect of OPC-8212 (3,4-dihydro-6-(4-(3,4-dimethoxy benzoyl)-1-piperazinyl)-2(1H)-quinolinone on myocardial oxygen consumption in dogs with ischemic heart failure.
    Japanese circulation journal, 1986, Volume: 50, Issue:7

    Topics: Animals; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Hemodynamics; Oxygen Consumption; Pyr

1986